+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032- Product Image
Neurodiagnostics Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Neurodiagnostics Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5014094
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurodiagnostics Market is projected to reach USD 15.97 Billion in 2026. It is expected to continue growing at a CAGR of 7.65%, reaching USD 24.92 Billion by 2032.

Neurodiagnostics is moving from episodic, hospital-centered testing toward connected, data-rich assessment of brain, nerve, muscle, and sleep disorders. Core modalities such as electroencephalography (EEG), electromyography (EMG), nerve conduction studies, evoked potentials, polysomnography, and intraoperative neuromonitoring are increasingly supported by cloud platforms, wearable sensors, remote monitoring tools, and advanced analytics.

Demand is grounded in measurable disease burden. The World Health Organization reports that neurological conditions affect billions of people globally and are among the leading causes of disability and illness worldwide, while aging populations are increasing the clinical need for diagnosis and monitoring of dementia, stroke, Parkinson’s disease, epilepsy, neuropathy, and sleep disorders. For providers, payers, and medtech leaders, neurodiagnostics is becoming a strategic gateway to earlier detection, longitudinal monitoring, and precision neurology.

Transformative Shifts in the Neurodiagnostics Landscape

The neurodiagnostics landscape is being reshaped by three structural shifts: site-of-care migration, digital workflow integration, and evidence-based specialization. Ambulatory EEG, home sleep testing, and remote monitoring are reducing dependence on inpatient laboratories, while hospitals are prioritizing interoperable systems that connect signal acquisition, interpretation, reporting, archiving, and electronic health records.

Regulatory and clinical expectations are also rising. FDA oversight of medical software, EU Medical Device Regulation requirements, cybersecurity rules, and data privacy frameworks are influencing product design, validation, procurement, and lifecycle management. At the same time, neurologists, sleep specialists, neurophysiologists, and technologists are adopting standardized protocols to improve diagnostic consistency, shorten time to interpretation, and support high-volume neurology practices.

Cumulative Impact of Artificial Intelligence in Neurodiagnostics

Artificial intelligence is becoming cumulative rather than experimental in neurodiagnostics. In EEG, AI-assisted event detection, seizure pattern recognition, artifact reduction, and triage can help clinicians review longer recordings more efficiently. In sleep diagnostics, automated scoring supports faster polysomnography interpretation, while neuromuscular and imaging-adjacent analytics can improve pattern detection when validated against expert clinical review.

The most credible AI value proposition is augmentation, not replacement. Health systems are favoring algorithms with transparent validation, bias assessment, clinical workflow fit, cybersecurity safeguards, and post-market performance monitoring. As multimodal datasets expand, AI is positioned to strengthen longitudinal neurology care by combining signal data, imaging, laboratory results, clinical notes, medication history, and patient-reported outcomes.

Key Regional Insights for Neurodiagnostics

Asia-Pacific is advancing through large patient volumes, expanding hospital networks, and national digital health programs, with China, Japan, India, South Korea, and Australia supporting adoption across epilepsy, dementia, stroke, neuromuscular disease, and sleep medicine. North America remains highly developed due to advanced neurology infrastructure, FDA-cleared technologies, reimbursement pathways, clinical trial density, and strong demand for ambulatory EEG, sleep diagnostics, and intraoperative neuromonitoring.

Latin America is improving access through private hospital investment and telehealth-enabled specialty care, particularly in Brazil and Mexico, where urban centers are expanding diagnostic capacity. Europe is shaped by universal health systems, GDPR, Medical Device Regulation compliance, and strong academic neurology networks that emphasize clinical evidence and standardized care. The Middle East is investing in tertiary hospitals, specialty neuroscience services, and medical tourism hubs, while Africa’s opportunity centers on scalable, lower-cost diagnostics, workforce training, mobile health models, and partnerships that expand neurological care beyond major urban centers.

Key Group Insights Across Strategic Economic Alliances

ASEAN demand is supported by rising noncommunicable disease burden, expanding private hospitals, and digital health initiatives in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, creating need for accessible EEG, sleep, and neuromuscular testing. The GCC is investing in advanced hospitals, specialty neurology centers, and AI-enabled healthcare infrastructure, creating opportunities for premium neurodiagnostic systems, clinical service partnerships, and managed diagnostic models.

The European Union emphasizes data protection, clinical evidence, and MDR-compliant innovation, making regulatory readiness and interoperability essential for adoption. BRICS markets combine large neurological patient pools with uneven access to specialists, favoring scalable devices, training programs, tele-neurodiagnostics, and local partnerships. G7 countries lead in research intensity, reimbursement sophistication, specialist availability, and clinical guideline adoption, while NATO countries prioritize resilient health systems, cybersecurity, and deployable medical technologies relevant to military medicine, trauma care, emergency neurology, and rehabilitation.

Key Country Insights in Neurodiagnostics

The United States leads adoption through major academic medical centers, integrated delivery networks, FDA pathways, and demand for EEG, sleep diagnostics, EMG, nerve conduction studies, and intraoperative neuromonitoring. Canada benefits from public health coverage, academic neurology networks, and tele-neurology expansion, while Mexico and Brazil are scaling access through private healthcare investment and growing specialist centers. The United Kingdom, Germany, France, Italy, and Spain combine strong clinical neurology capacity with strict evidence, procurement, and data protection requirements, and Russia maintains demand for hospital-based neurological diagnostics despite market access and supply-chain complexity.

China is expanding neurodiagnostic capacity through hospital modernization, domestic medtech development, and national digital health priorities. India offers high-volume opportunity as neurology access improves across metropolitan and tier-two markets, supported by rising awareness of epilepsy, stroke, neuropathy, and sleep disorders. Japan’s aging population supports dementia, stroke, Parkinson’s disease, and sleep diagnostics, while South Korea emphasizes digital hospitals, advanced medical technology, and high connectivity. Australia combines strong clinical standards with remote-care needs that favor tele-neurodiagnostics, connected testing models, and specialist access across geographically dispersed communities.

Actionable Recommendations for Neurodiagnostics Industry Leaders

Industry leaders should prioritize clinically validated neurodiagnostic platforms that improve throughput, diagnostic confidence, interoperability, and specialist productivity. Product strategies should focus on ambulatory EEG, home sleep testing, remote patient monitoring, cloud-based review, automated reporting, and AI-enabled workflow tools that demonstrate measurable time savings, reproducibility, and quality improvement.

Commercial execution should align with regional reimbursement, data privacy, cybersecurity, clinical evidence, and procurement realities. Organizations should invest in validation studies, local service networks, technologist training, multilingual user support, and partnerships with neurology, sleep, and surgical monitoring centers. Scalable pricing, modular configurations, and education-led market development can improve adoption in emerging economies while preserving premium positioning in advanced healthcare systems.

Research Methodology

This executive summary applies a structured secondary research methodology using verified public sources, regulatory information, clinical guidelines, epidemiological evidence, and market-facing signals. Inputs include published information from organizations such as the WHO, CDC, FDA, European regulatory frameworks, national health agencies, professional neurology and sleep societies, hospital procurement references, and peer-reviewed medical literature.

Insights were synthesized through triangulation across neurological disease burden, technology adoption, regulatory environment, healthcare infrastructure, workforce availability, reimbursement conditions, and regional access dynamics. The analysis avoids unsupported projections and focuses on evidence-backed drivers shaping neurodiagnostics demand, including aging demographics, neurological disease prevalence, digital health adoption, AI validation requirements, remote-care expansion, and care-delivery transformation.

Conclusion

Neurodiagnostics is entering a period of sustained modernization as neurological disease burden rises and health systems seek earlier, faster, and more accessible assessment tools. The strongest opportunities are linked to connected diagnostics, AI-assisted interpretation, ambulatory testing, home-based sleep assessment, and workflow platforms that help specialists manage increasing case complexity.

Winning organizations will combine clinical rigor with digital scalability. Vendors that prove accuracy, usability, interoperability, privacy protection, cybersecurity, service reliability, and economic value will be best positioned across mature and emerging markets. As neurology becomes more data-driven, neurodiagnostics will remain central to precision care, chronic disease management, surgical safety, and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurodiagnostics Market, by Device Type
7.1. Neuroimaging Devices
7.1.1. Magnetic Resonance Imaging (MRI) Systems
7.1.2. Computed Tomography (CT) Scanners
7.1.3. Positron Emission Tomography (PET) Systems
7.1.4. Single Photon Emission Computed Tomography (SPECT)
7.2. Neurophysiology Devices
7.2.1. Electroencephalography (EEG) Systems
7.2.2. Electromyography (EMG) Systems
7.2.3. Nerve Conduction Study (NCS) Devices
7.2.4. Evoked Potential (EP) Systems
8. Neurodiagnostics Market, by Technology
8.1. Invasive
8.1.1. Depth Electrode Monitoring
8.1.2. Electrocorticography
8.2. Noninvasive
8.2.1. Electrophysiology
8.2.2. Imaging Modalities
9. Neurodiagnostics Market, by Application
9.1. Alzheimer's Disease
9.1.1. Lewy Body Dementia
9.1.2. Vascular Dementia
9.2. Brain Tumor
9.3. Epilepsy
9.3.1. Focal Epilepsy
9.3.2. Generalized Epilepsy
9.4. Multiple Sclerosis
9.5. Stroke
9.5.1. Hemorrhagic Stroke
9.5.2. Ischemic Stroke
9.6. Trauma
10. Neurodiagnostics Market, by End User
10.1. Ambulatory Clinics
10.1.1. Neurology Clinics
10.1.2. Outpatient Rehabilitation Centers
10.2. Diagnostic Centers
10.2.1. Hospital Owned Diagnostic Centers
10.2.2. Independent Diagnostic Centers
10.3. Home Care
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialty Clinics
10.5. Research Institutes
11. Asia-Pacific Neurodiagnostics Market
12. Europe Neurodiagnostics Market
13. North America Neurodiagnostics Market
14. Latin America Neurodiagnostics Market
15. Africa Neurodiagnostics Market
16. Middle East Neurodiagnostics Market
17. NATO Neurodiagnostics Market
18. G7 Neurodiagnostics Market
19. BRICS Neurodiagnostics Market
20. European Union Neurodiagnostics Market
21. ASEAN Neurodiagnostics Market
22. GCC Neurodiagnostics Market
23. China Neurodiagnostics Market
24. United States Neurodiagnostics Market
25. Japan Neurodiagnostics Market
26. India Neurodiagnostics Market
27. Germany Neurodiagnostics Market
28. United Kingdom Neurodiagnostics Market
29. Australia Neurodiagnostics Market
30. France Neurodiagnostics Market
31. South Korea Neurodiagnostics Market
32. Italy Neurodiagnostics Market
33. Canada Neurodiagnostics Market
34. Russia Neurodiagnostics Market
35. Brazil Neurodiagnostics Market
36. Mexico Neurodiagnostics Market
37. Spain Neurodiagnostics Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. Advanced Brain Monitoring, Inc.
39.2. BioSerenity
39.3. Brainscope Co. Inc.
39.4. Cadwell Laboratories, Inc.
39.5. Canon Medical Systems Corporation
39.6. Compumedics Limited
39.7. Electrical Geodesics, Inc.
39.8. F. Hoffmann-La Roche Ltd
39.9. FUJIFILM Holdings Corporation
39.10. GE HealthCare Corporation
39.11. Koninklijke Philips N.V.
39.12. Lifelines Neuro Company, LLC
39.13. Medtronic plc
39.14. Natus Medical Incorporated
39.15. NeuroMetrix, Inc.
39.16. Neurosigma, Inc.
39.17. NeuroSky, Inc.
39.18. Neurosoft
39.19. Nicolet Neurodiagnostic Products, Inc.
39.20. Nihon Kohden Corporation
39.21. Persyst Development Corporation
39.22. Rhythmlink International, LLC
39.23. Siemens Healthineers AG
39.24. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL NEURODIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. NATO NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. NATO NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. G7 NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. G7 NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. BRICS NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. BRICS NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. CHINA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. JAPAN NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. INDIA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. FRANCE NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. ITALY NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CANADA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEURODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NONINVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NONINVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NONINVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMAGING MODALITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMAGING MODALITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN TUMOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN TUMOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN TUMOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 147. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 148. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 193. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 196. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 198. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 202. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 203. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 219. NATO NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. NATO NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 221. NATO NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 222. NATO NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 223. NATO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. NATO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 225. NATO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 226. NATO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. NATO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 228. NATO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 229. NATO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 230. NATO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. NATO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 232. NATO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 233. NATO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 234. G7 NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 235. G7 NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 236. G7 NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 237. G7 NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 238. G7 NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. G7 NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 240. G7 NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 241. G7 NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. G7 NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 243. G7 NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 244. G7 NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 245. G7 NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. G7 NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 247. G7 NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 248. G7 NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. BRICS NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 250. BRICS NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 252. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 253. BRICS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. BRICS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 255. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 256. BRICS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. BRICS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 258. BRICS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 259. BRICS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 260. BRICS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. BRICS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 262. BRICS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 263. BRICS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 279. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 280. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 281. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 283. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 285. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 286. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 288. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 289. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 290. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 292. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 293. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 294. GCC NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 295. GCC NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 296. GCC NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 297. GCC NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 298. GCC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. GCC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 300. GCC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 301. GCC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 302. GCC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 303. GCC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 304. GCC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 305. GCC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. GCC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 307. GCC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 308. GCC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 309. CHINA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 310. CHINA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 311. CHINA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 312. CHINA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 313. CHINA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 315. CHINA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 316. CHINA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 317. CHINA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 318. CHINA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 319. CHINA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 320. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. CHINA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 322. CHINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 323. CHINA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 332. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 333. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 334. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 335. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 336. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 337. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 338. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 339. JAPAN NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 341. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 342. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 343. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 344. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 345. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 346. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 347. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 348. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 349. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 350. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 351. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 352. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 353. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 354. INDIA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 355. INDIA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 356. INDIA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 357. INDIA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
TABLE 358. INDIA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 359. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 360. INDIA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 361. INDIA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 362. INDIA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 363. INDIA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 364. INDIA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 365. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 366. INDIA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 367. INDIA NEURODIAGNOSTICS MARK

Companies Mentioned

The companies featured in this Neurodiagnostics market report include:
  • Advanced Brain Monitoring, Inc.
  • BioSerenity
  • Brainscope Co. Inc.
  • Cadwell Laboratories, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Electrical Geodesics, Inc.
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE HealthCare Corporation
  • Koninklijke Philips N.V.
  • Lifelines Neuro Company, LLC
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroMetrix, Inc.
  • Neurosigma, Inc.
  • NeuroSky, Inc.
  • Neurosoft
  • Nicolet Neurodiagnostic Products, Inc.
  • Nihon Kohden Corporation
  • Persyst Development Corporation
  • Rhythmlink International, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.97 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.92 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Neurodiagnostics Market Size, Share & Trends Analysis Report by Technology, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Neurodiagnostics Market Size, Share & Trends Analysis Report by Technology, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Neurodiagnostics Market Report 2026 - Product Image

Neurodiagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neurodiagnostics Market Outlook 2026-2034: Market Share and Growth Analysis by Product (Reagents & Consumables, Clinical Testing Instruments, Diagnostic & Imaging Systems), Technology, Condition, End User - Product Image

Neurodiagnostics Market Outlook 2026-2034: Market Share and Growth Analysis by Product (Reagents & Consumables, Clinical Testing Instruments, Diagnostic & Imaging Systems), Technology, Condition, End User

  • Report
  • 160 Pages
  • Global
From
2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.